No headlines found.
VITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama
Business Wire (Wed, 13-Mar 9:00 AM ET)
Chemed Corporation to Present at the Oppenheimer 34th Annual Healthcare Conference
Business Wire (Fri, 8-Mar 12:00 PM ET)
Chemed Reports Fourth-Quarter 2023 Results
Business Wire (Tue, 27-Feb 4:15 PM ET)
Chemed Corporation Declares Quarterly Dividend of 40 Cents
Business Wire (Fri, 16-Feb 12:27 PM ET)
Business Wire (Wed, 14-Feb 12:00 PM ET)
Chemed Corporation to Present at the 42nd Annual JPMorgan Healthcare Conference
Business Wire (Fri, 29-Dec 12:00 PM ET)
Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue. It provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segment's revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. Chemed generates the majority of its revenue from business in the United States.
Chemed trades on the NYSE stock market under the symbol CHE.
As of March 28, 2024, CHE stock price climbed to $646.71 with 18,178 million shares trading.
CHE has a beta of 0.21, meaning it tends to be less sensitive to market movements. CHE has a correlation of 0.02 to the broad based SPY ETF.
CHE has a market cap of $9.74 billion. This is considered a Mid Cap stock.
Last quarter Chemed reported $586 million in Revenue and $6.60 earnings per share. This fell short of revenue expectation by $-728,000 and exceeded earnings estimates by $.35.
In the last 3 years, CHE stock traded as high as $654.62 and as low as $403.00.
The top ETF exchange traded funds that CHE belongs to (by Net Assets): IJH, VTI, VB, VXF, VBK.
CHE has underperformed the market in the last year with a price return of +23.2% while the SPY ETF gained +33.7%. CHE has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +9.7% and 0.0%, respectively, while the SPY returned +10.2% and +1.8%, respectively.
CHE support price is $636.12 and resistance is $652.40 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CHE stock will trade within this expected range on the day.